Schunemann, Holger Jens
 Distribuzione geografica
Continente #
AS - Asia 3.813
NA - Nord America 3.187
SA - Sud America 1.100
EU - Europa 861
Continente sconosciuto - Info sul continente non disponibili 236
AF - Africa 121
OC - Oceania 16
Totale 9.334
Nazione #
US - Stati Uniti d'America 3.019
SG - Singapore 2.203
BR - Brasile 907
CN - Cina 552
VN - Vietnam 484
IT - Italia 371
HK - Hong Kong 210
AR - Argentina 81
CA - Canada 66
GB - Regno Unito 65
MX - Messico 64
DE - Germania 60
IN - India 59
FI - Finlandia 52
FR - Francia 51
BD - Bangladesh 44
ID - Indonesia 40
EC - Ecuador 38
TR - Turchia 38
NL - Olanda 37
PL - Polonia 32
ZA - Sudafrica 31
ES - Italia 30
IE - Irlanda 28
IQ - Iraq 28
RU - Federazione Russa 28
NG - Nigeria 25
UA - Ucraina 22
JP - Giappone 21
VE - Venezuela 19
CO - Colombia 18
AT - Austria 15
PK - Pakistan 15
MA - Marocco 14
AU - Australia 13
UZ - Uzbekistan 13
KE - Kenya 12
NP - Nepal 12
SE - Svezia 12
DZ - Algeria 11
PY - Paraguay 11
CL - Cile 10
MY - Malesia 10
HR - Croazia 9
JM - Giamaica 9
SA - Arabia Saudita 9
AE - Emirati Arabi Uniti 8
UY - Uruguay 8
CH - Svizzera 6
PT - Portogallo 6
SN - Senegal 6
TH - Thailandia 6
TN - Tunisia 6
BE - Belgio 5
CR - Costa Rica 5
EG - Egitto 5
IR - Iran 5
KZ - Kazakistan 5
LT - Lituania 5
MD - Moldavia 5
AZ - Azerbaigian 4
BH - Bahrain 4
CZ - Repubblica Ceca 4
GE - Georgia 4
GT - Guatemala 4
HN - Honduras 4
IL - Israele 4
JO - Giordania 4
KR - Corea 4
PE - Perù 4
BG - Bulgaria 3
EE - Estonia 3
KH - Cambogia 3
OM - Oman 3
PA - Panama 3
PH - Filippine 3
PS - Palestinian Territory 3
SY - Repubblica araba siriana 3
AO - Angola 2
BN - Brunei Darussalam 2
CY - Cipro 2
DO - Repubblica Dominicana 2
HU - Ungheria 2
KG - Kirghizistan 2
LK - Sri Lanka 2
LV - Lettonia 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
PR - Porto Rico 2
SV - El Salvador 2
TW - Taiwan 2
AL - Albania 1
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
BW - Botswana 1
BZ - Belize 1
CI - Costa d'Avorio 1
CU - Cuba 1
ET - Etiopia 1
GA - Gabon 1
Totale 9.078
Città #
Singapore 774
Ashburn 517
San Jose 506
The Dalles 453
Beijing 244
Dallas 207
Hong Kong 198
Ho Chi Minh City 175
Wilmington 130
Hanoi 110
Milan 102
Santa Clara 86
São Paulo 86
Shanghai 68
Los Angeles 67
New York 57
Helsinki 50
Rome 45
San Mateo 45
Mexico City 38
Buffalo 31
Assago 30
Amsterdam 27
Dublin 26
Orem 26
Princeton 24
Rio de Janeiro 23
Toronto 23
Fairfield 22
Leawood 22
Ann Arbor 21
Lawrence 21
London 21
Benin City 20
Da Nang 20
Warsaw 20
Boardman 19
Haiphong 19
Naples 18
Porto Alegre 18
Biên Hòa 17
Brasília 17
Johannesburg 17
Belo Horizonte 16
Tokyo 15
Brooklyn 14
Chennai 14
Guayaquil 14
Montreal 14
Turin 14
Baghdad 13
Chicago 13
Florence 13
Guarulhos 13
Atlanta 12
Denver 12
Paris 12
Philadelphia 12
Salvador 12
San Francisco 12
Tashkent 12
Frankfurt am Main 11
Phoenix 11
Boston 10
Chandler 10
Houston 10
Istanbul 10
Ninh Bình 10
Quito 10
Recife 10
Campinas 9
Charlotte 9
Goiânia 9
Zagreb 9
Buenos Aires 8
Can Tho 8
Curitiba 8
Dhaka 8
Kocaeli 8
Madrid 8
Nairobi 8
Bologna 7
Canoas 7
Caracas 7
Caxias do Sul 7
Cleveland 7
Montevideo 7
New Delhi 7
Newton 7
Quảng Ngãi 7
Ribeirão Preto 7
Santo André 7
Uberlândia 7
Ankara 6
Contagem 6
Dakar 6
Figino 6
Hillsboro 6
Jakarta 6
Manaus 6
Totale 5.007
Nome #
DOACs vs LMWHs in hospitalized medical patients: a systematic review and meta-analysis that informed 2018 ASH guidelines 188
Allergic Rhinitis and its Impact on Asthma (ARIA) Phase 4 (2018): Change management in allergic rhinitis and asthma multimorbidity using mobile technology 119
Aligning the Good Practice MASK With the Objectives of the European Innovation Partnership on Active and Healthy Ageing 102
Intranasal Versus Oral Treatments for Allergic Rhinitis: A Systematic Review With Meta-Analysis 97
World Allergy Organization-McMaster University Guidelines for Allergic Disease Prevention (GLAD-P): Prebiotics 83
Empirical estimation of disutilities and decision thresholds for composite endpoints 80
Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines-2016 revision 80
World Allergy Organization (WAO) Diagnosis and Rationale for Action against Cow's Milk Allergy (DRACMA) guideline update – XII – Recommendations on milk formula supplements with and without probiotics for infants and toddlers with CMA 78
MACVIA-ARIA Sentinel NetworK for allergic rhinitis (MASK-rhinitis): The new generation guideline implementation 77
World Allergy Organization-McMaster University Guidelines for Allergic Disease Prevention (GLAD-P): Probiotics 77
Analytical frameworks in colorectal cancer guidelines: development of methods for systematic reviews, their application and practical guidance for their use 71
Conclusions from surveys may not consider important biases: a systematic survey of surveys 71
GA2LEN (Global Allergy and Asthma European Network) addresses the allergy and asthma 'epidemic' 71
Integrated care pathways for airway diseases (AIRWAYS-ICPs) 71
How to design and evaluate randomized controlled trials in immunotherapy for allergic rhinitis: an ARIA-GA(2) LEN statement 69
World Allergy Organization-McMaster University Guidelines for Allergic Disease Prevention (GLAD-P): Vitamin D 68
ARIA-EAACI care pathways for allergen immunotherapy in respiratory allergy 68
Recommendations on the use of restrictions and assistive devices after total hip arthroplasty: an adolopment of guidelines 67
Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5) 67
Diagnosis and Rationale for Action Against Cow's Milk Allergy (DRACMA): a summary report 67
ARIA 2016: Care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle 67
A Framework for the Development of Living Practice Guidelines in Health Care 66
Erratum to: Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5)(Clin Transl Allergy (2016) 6 (29) DOI: 10.1186/s13601-016-0116-9) 66
ARIA 2016 executive summary: Integrated care pathways for predictive, preventive and personalized medicine across the life cycle 65
Beta₂-agonists for exercise-induced asthma 65
Next-generation Allergic Rhinitis and Its Impact on Asthma (ARIA) guidelines for allergic rhinitis based on Grading of Recommendations Assessment, Development and Evaluation (GRADE) and real-world evidence 64
AIRWAYS-ICPs (European Innovation Partnership on Active and Healthy Ageing) from concept to implementation 63
The Consolidated Standards of Reporting Trials (CONSORT) Statement applied to allergen-specific immunotherapy with inhalant allergens: a Global Allergy and Asthma European Network (GA(2)LEN) article 63
Intranasal antihistamines and corticosteroids in allergic rhinitis: A systematic review and meta-analysis 62
World Allergy Organization (WAO) Diagnosis and Rationale for Action against Cow's Milk Allergy (DRACMA) Guidelines update – I – Plan and definitions 61
Addressing uncertainty in relative effectiveness assessments by HTA organizations 60
A risk of bias instrument for non-randomized studies of exposures: A users’ guide to its application in the context of GRADE 60
Important research questions in allergy and related diseases: nonallergic rhinitis: a GA2LEN paper 58
Development of an international glossary for clinical guidelines collaboration 57
ROBVALU: a tool for assessing risk of bias in studies about people’s values, utilities, or importance of health outcomes 55
Meta-analysis: Use of proton pump inhibitors and risk of gastric cancer in patients requiring gastric acid suppression 54
Panel stacking is a threat to consensus statement validity 52
Evaluating the credibility of anchor based estimates of minimal important differences for patient reported outcomes: instrument development and reliability study 52
A Theoretical Framework and Competency-Based Approach to Training in Guideline Development 50
American Society of Hematology 2021 guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19 50
Guideline-based quality assurance: a conceptual framework for the definition of key elements 50
GRADE GUIDANCE 38: Updated guidance for rating up certainty of evidence due to a dose-response gradient 50
Assessing the process and outcome of the development of practice guidelines and recommendations: PANELVIEW instrument development 50
GRADE concept paper 2: Concepts for judging certainty on the calibration of prognostic models in a body of validation studies 50
GRADE guidelines 26: informative statements to communicate the findings of systematic reviews of interventions 50
Breast Cancer Screening and Diagnosis: A Synopsis of the European Breast Guidelines 49
Impact of polyunsaturated fatty acids on patient-important outcomes in children and adolescents with autism spectrum disorder: a systematic review 49
The ecosystem of health decision making: from fragmentation to synergy 49
A multistakeholder development process to prioritize and translate COVID-19 health recommendations for patients, caregivers and the public. A case study of the COVID-19 recommendation map 48
A tool to assess risk of bias in non-randomized follow-up studies of exposure effects (ROBINS-E) 48
Key issues for stakeholder engagement in the development of health and healthcare guidelines 47
Challenges in applying the GRADE approach in public health guidelines and systematic reviews: a concept article from the GRADE Public Health Group 47
American Society of Hematology 2023 guidelines for management of venous thromboembolism: thrombophilia testing 47
Reaction Risk to Direct Penicillin Challenges: A Systematic Review and Meta-Analysis 46
Tailored PRISMA 2020 flow diagrams for living systematic reviews: a methodological survey and a proposal 46
A multimethods randomized trial found that plain language versions improved adults understanding of health recommendations 46
GRADE Guidance: 31. Assessing the certainty across a body of evidence for comparative test accuracy 46
Monitoring and evaluation of breast cancer screening programmes: selecting candidate performance indicators 46
Prospective collaborative recommendation development: a novel model for more timely and trustworthy guidelines 46
Evaluating prophylactic heparin in ambulatory patients with solid tumours: a systematic review and individual participant data meta-analysis 46
Reporting Conflicts of Interest and Funding in Health Care Guidelines: The RIGHT-COI&F Checklist 46
Development and use of health outcome descriptors: a guideline development case study 46
GRADE guidelines: 21 part 1. Study design, risk of bias, and indirectness in rating the certainty across a body of evidence for test accuracy 45
Introduction and methods of the evidence-based guidelines for the diagnosis and management of autism spectrum disorder by the Italian National Institute of Health 45
We're living through a planetary health crisis: health guidelines must consider planetary health 45
Grading of recommendations assessment, development, and evaluation concept article 5: addressing intransitivity in a network meta-analysis 45
Efficacy and safety of intranasal medications for allergic rhinitis: Network meta‐analysis 45
Impact of antipsychotics in children and adolescents with autism spectrum disorder: a systematic review and meta-analysis 44
Equity issues rarely addressed in the development of COVID-19 formal recommendations and good practice statements: a cross-sectional study 44
Grading of Recommendations Assessment, Development, and Evaluations (GRADE) notes: extremely serious, GRADE's terminology for rating down by three levels 44
GRADE approach to drawing conclusions from a network meta-analysis using a minimally contextualised framework 44
A memorandum of understanding has facilitated guideline development involving collaborating groups 44
Obtaining and managing data sets for individual participant data meta-analysis: scoping review and practical guide 44
Letter: Potassium-competitive acid blockers may increase the risk of gastric cancer after Helicobacter pylori eradication—a retrospective multicentre-cohort analysis. Authors' reply 43
Using GRADE Evidence to Decision frameworks to support the process of health policy-making: an example application regarding taxation of sugar-sweetened beverages 43
Acceptability, equity, and feasibility of using antipsychotics in children and adolescents with autism spectrum disorder: a systematic review 43
A practical guide for using a survey about attitudes and behaviors to inform health care decisions 43
World Allergy Organization (WAO) Diagnosis and Rationale for Action against Cow's Milk Allergy (DRACMA) guidelines update – XVI - Nutritional management of cow's milk allergy 42
GRADE guidelines 27: how to calculate absolute effects for time-to-event outcomes in summary of findings tables and Evidence Profiles 42
Artificial Intelligence–Supported Development of Health Guideline Questions 42
Prevalence of co-occurring conditions in children and adults with autism spectrum disorder: A systematic review and meta-analysis 42
Management of heparin-induced thrombocytopenia: systematic reviews and meta-analyses 42
PROTOCOL: Guidance for stakeholder engagement in guideline development: A systematic review 42
GRADE approach to drawing conclusions from a network meta-analysis using a partially contextualised framework 42
The Conundrum of Giglio Island: Unraveling the dynamics of an apparent resistance to COVID-19 – A descriptive study 42
A multimethods randomized trial found that plain language versions improved parents’ understanding of health recommendations 42
Use of heparins in patients with cancer: individual participant data meta-analysis of randomised trials study protocol 42
Protocol for the development of guidance for stakeholder engagement in health and healthcare guideline development and implementation 42
American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: July 2021 update on postdischarge thromboprophylaxis 42
Guidelines 2.0: systematic development of a comprehensive checklist for a successful guideline enterprise 42
GRADE Guidelines: 29. Rating the certainty in time-to-event outcomes—Study limitations due to censoring of participants with missing data in intervention studies 41
Comparison of evidence of treatment effects in randomized and nonrandomized studies on allergen immunotherapy 41
2019 ARIA Care Pathways for Allergic Rhinitis-Turkey 41
GRADE guidance 37: rating imprecision in a body of evidence on test accuracy 41
Decision criteria for selecting essential medicines and their connection to guidelines: an interpretive descriptive qualitative interview study 41
Cross-cultural adaptation and validation to Spanish of the PANELVIEW instrument to evaluate the health guidelines development process 41
Use of facemasks during the COVID-19 pandemic 41
Plain Language vs Standard Format for Youth Understanding of COVID-19 Recommendations: A Randomized Clinical Trial 40
Intranasal antihistamines and corticosteroids in the treatment of allergic rhinitis: a systematic review and meta-analysis protocol 40
The Khorana score for prediction of venous thromboembolism in cancer patients: An individual patient data meta‐analysis 40
Totale 5.523
Categoria #
all - tutte 47.642
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 47.642


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202296 0 0 1 22 1 0 2 14 10 19 23 4
2022/2023120 43 2 24 3 2 2 5 1 6 24 6 2
2023/2024160 7 15 24 3 3 10 16 6 8 4 22 42
2024/20252.044 14 2 1 6 5 42 394 164 246 584 281 305
2025/20266.324 850 438 394 871 238 290 1.271 394 373 472 229 504
2026/2027340 337 3 0 0 0 0 0 0 0 0 0 0
Totale 9.334